Laurus Labs

Laurus Labs EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of Laurus Labs (LAURUSLABS.NS) as of Nov 4, 2026 is 12.35 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was 7.54 % — a change of 63.66% (higher).

EBIT/Assets

12.35 %

YoY

63.66%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Laurus Labs is 2026 12.35 % . Operating Income to Assets Ratio (EBIT/Assets) of Laurus Labs was 2025 7.54 % . It decreases by 63.66% higher compared to the previous year.

The Laurus Labs EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2019
21.33 INR
Jan 1, 2020
10.22 INR
Jan 1, 2021
37.55 INR
Jan 1, 2022
30.90 INR
Jan 1, 2023
33.36 INR
Jan 1, 2024
4.93 INR
Jan 1, 2025
7.54 INR
Jan 1, 2026
12.35 INR
The Laurus Labs EBIT/Assets history
YEAREBIT/AssetsYoY
12.35 %+63.66%
7.54 %+53.07%
4.93 %-85.23%
33.36 %+7.98%
30.90 %-17.71%
37.55 %+267.51%
10.22 %-52.11%
21.33 %-8.34%
23.27 %-5.92%
24.74 %+2.01%
24.25 %+197.14%
8.16 %-30.91%
11.81 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Laurus Labs Stock analysis

What does Laurus Labs do? Laurus Labs Ltd is an Indian pharmaceutical company specializing in the production of active pharmaceutical ingredients for generics and innovative drugs. Since its establishment in 2005, the company has become one of the leading providers of API products on the global market. Answer: Laurus Labs Ltd is an Indian pharmaceutical company specializing in the production of active pharmaceutical ingredients for generics and innovative drugs. Laurus Labs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Laurus Labs stock

Operating Income to Assets Ratio (EBIT/Assets) of Laurus Labs is 12.35 % in 2026.

Operating Income to Assets Ratio (EBIT/Assets) of Laurus Labs changed from 7.54 % to 12.35 %, representing a 63.66% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Laurus Labs since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Laurus Labs with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Laurus Labs

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Laurus Labs